menu search

curium receives marketing authorization in the eu for pylclari™, an innovative 18f-psma pet tracer indicated in adults with prostate cancer

PARIS, July 28, 2023 (GLOBE NEWSWIRE) — curium, a world leader in nuclear medicine, announced that th...

July 28, 2023, 10:12 am

curium announces publication of [18f]dcfpyl versus [18f]fluoromethylcholine results from european phase iii study (python trial)

PARIS, July 21, 2023 (GLOBE NEWSWIRE) — curium, a world leader in nuclear medicine, announced today t...

July 21, 2023, 7:30 am

curium announces last patient enrolled in their phase 1/2 solar clinical trial imaging men with histologically-proven metastatic prostate cancer using copper cu 64 psma i&t.

PARIS, May 23, 2023 (GLOBE NEWSWIRE) — curium, a world leader in nuclear medicine, announced today th...

May 23, 2023, 4:57 pm

Innovation and growing demand for nuclear medicine drives curium expansion and 10-year commitment to st. louis, mo

Renaissance in nuclear medicine to attract top St. Louis talent North America Headquarters to call Westport Plaza home for the next 10 years Over 100 ...

March 2, 2023, 12:44 pm

South star battery metals reports promising curium drill results from ceylon project

South Star Battery Metals Corp. (TSX-V:STS, OTCQB:STSBF) said it has completed the maiden drilling campaign at its Ceylon Project in Alabama on sche...

December 12, 2022, 9:35 am


Search within

Pages Search Results: